AssetMark Inc
ADMA icon

AssetMark Inc’s ADMA Biologics ADMA Stock Holding History

AssetMark Inc’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$512 Buy
+51
New +$472 ﹤0.01% 3401
2026
Q1 		– Sell
-5
Closed -$91 – 3442
2025
Q4 		$91 Hold
5
– – ﹤0.01% 3311
2025
Q3 		$73 Hold
5
– – ﹤0.01% 3136
2025
Q2 		$91 Buy
+5
New +$102 ﹤0.01% 2946

Other funds holding ADMA

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Marathon Capital Management
Marathon Capital Management Hunt Valley, Maryland $488M AUM 28.5% 1-Year Est. Return
Bridge City Capital
Bridge City Capital Lake Oswego, Oregon $480M AUM 47.16% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
STRS Ohio
STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Louisiana State Employees Retirement System
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.56B AUM 41.43% 1-Year Est. Return

AssetMark Inc's ADMA Position: Q3 2026 in Review

AssetMark Inc opened a new position in ADMA Biologics (ADMA) in Q3 2026: 51 shares worth $512. The stake represents ﹤0.01% of the portfolio and ranks #3401 among its holdings. This is a return to the name: AssetMark Inc previously reported a position in ADMA as recently as Q4 2025.

AssetMark Inc first reported a position in ADMA in Q2 2025 and has held it in 4 quarters since. 117 funds tracked by Wall St. Rank hold ADMA as of Q3 2026.

  • AssetMark Inc held 51 shares of ADMA Biologics worth $512 as of Q3 2026.
  • ADMA Biologics was a new AssetMark Inc position in Q3 2026.
  • ADMA Biologics made up ﹤0.01% of AssetMark Inc's portfolio in Q3 2026, its #3401 holding.
  • AssetMark Inc first reported a position in ADMA Biologics in Q2 2025 and has held it in 4 quarters since.
  • 117 funds tracked by Wall St. Rank held ADMA Biologics as of Q3 2026.

Based on AssetMark Inc's 13F filing for Q3 2026, filed 21 Oct 2026.